Archford Capital Strategies, LLC Cooper Companies, Inc. Transaction History

Archford Capital Strategies, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 24, 2020	SELL	$270.93 - $320.3 $320,510 - $378,914	-1,183 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$243.44 - $359.98 $52,583 - $77,755	216 Added 22.34%	1,183 $326,000
Q4 2019 Jan 15, 2020	SELL	$281.18 - $322.05 $2,530 - $2,898	-9 Reduced 0.92%	967 $311,000
Q3 2019 Oct 23, 2019	BUY	$294.25 - $341.49 $9,121 - $10,586	31 Added 3.28%	976 $290,000
Q2 2019 Jul 18, 2019	BUY	$279.29 - $336.89 $837 - $1,010	3 Added 0.32%	945 $318,000
Q1 2019 May 13, 2019	BUY	$246.18 - $297.25 $10,339 - $12,484	42 Added 4.67%	942 $279,000
Q4 2018 Feb 13, 2019	SELL	$232.7 - $281.66 $6,282 - $7,604	-27 Reduced 2.91%	900 $229,000
Q3 2018 Nov 14, 2018	BUY	$236.3 - $277.15 $5,907 - $6,928	25 Added 2.77%	927 $257,000
Q2 2018 Aug 14, 2018	BUY	$217.98 - $237.23 $40,762 - $44,362	187 Added 26.15%	902 $212,000
Q1 2018 May 14, 2018	SELL	$218.74 - $251.43 $64,747 - $74,423	-296 Reduced 29.28%	715 $156,000
Q2 2017 Aug 18, 2017	BUY	N/A	1,011	1,011 $58,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Archford Capital Strategies, LLC with notifications on news.